HUE073295T2 - Tetrazol származékok mint TRPA1 gátlók - Google Patents

Tetrazol származékok mint TRPA1 gátlók

Info

Publication number
HUE073295T2
HUE073295T2 HUE21735303A HUE21735303A HUE073295T2 HU E073295 T2 HUE073295 T2 HU E073295T2 HU E21735303 A HUE21735303 A HU E21735303A HU E21735303 A HUE21735303 A HU E21735303A HU E073295 T2 HUE073295 T2 HU E073295T2
Authority
HU
Hungary
Prior art keywords
tetrazole derivatives
trpa1 inhibitors
trpa1
inhibitors
tetrazole
Prior art date
Application number
HUE21735303A
Other languages
English (en)
Inventor
Florian Binder
Martin Fleck
Jens Willwacher
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of HUE073295T2 publication Critical patent/HUE073295T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUE21735303A 2020-06-29 2021-06-25 Tetrazol származékok mint TRPA1 gátlók HUE073295T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20182988 2020-06-29

Publications (1)

Publication Number Publication Date
HUE073295T2 true HUE073295T2 (hu) 2026-01-28

Family

ID=71401656

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE21735303A HUE073295T2 (hu) 2020-06-29 2021-06-25 Tetrazol származékok mint TRPA1 gátlók

Country Status (32)

Country Link
US (2) US11884652B2 (hu)
EP (1) EP4171563B1 (hu)
JP (1) JP7539501B2 (hu)
KR (1) KR20230028547A (hu)
CN (3) CN121085901A (hu)
AR (1) AR122779A1 (hu)
AU (1) AU2021298800A1 (hu)
BR (1) BR112022021865A2 (hu)
CA (1) CA3181350A1 (hu)
CL (1) CL2022003329A1 (hu)
CO (1) CO2022016755A2 (hu)
CR (1) CR20220667A (hu)
DK (1) DK4171563T3 (hu)
DO (1) DOP2022000262A (hu)
EC (1) ECSP22088664A (hu)
ES (1) ES3049803T3 (hu)
FI (1) FI4171563T3 (hu)
HR (1) HRP20251260T1 (hu)
HU (1) HUE073295T2 (hu)
IL (1) IL299175A (hu)
JO (1) JOP20220350A1 (hu)
LT (1) LT4171563T (hu)
MA (1) MA60100B1 (hu)
MX (1) MX2022016357A (hu)
PE (1) PE20231852A1 (hu)
PL (1) PL4171563T3 (hu)
PT (1) PT4171563T (hu)
RS (1) RS67325B1 (hu)
SA (1) SA522441965B1 (hu)
SI (1) SI4171563T1 (hu)
TW (1) TWI907452B (hu)
WO (1) WO2022002782A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202309015A (zh) 2021-04-14 2023-03-01 德商百靈佳殷格翰國際股份有限公司 作為trpa1抑制劑之尿嘧啶衍生物
US20250136587A1 (en) * 2022-02-03 2025-05-01 D. E. Shaw Research, Llc N3-substituted uracil compounds as trpa1 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361654B2 (en) 2005-01-13 2008-04-22 Bristol-Myers Squibb Co. Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
JP2011231015A (ja) * 2008-08-29 2011-11-17 Taiho Yakuhin Kogyo Kk 含窒素複素環を有する新規ウラシル化合物又はその塩
WO2017060488A1 (en) 2015-10-09 2017-04-13 Almirall, S.A. New trpa1 antagonists
WO2018096159A1 (en) * 2016-11-28 2018-05-31 F. Hoffmann-La Roche Ag Oxadiazolones as transient receptor potential channel inhibitors
TW202309015A (zh) 2021-04-14 2023-03-01 德商百靈佳殷格翰國際股份有限公司 作為trpa1抑制劑之尿嘧啶衍生物

Also Published As

Publication number Publication date
PL4171563T3 (pl) 2026-02-09
US20220002270A1 (en) 2022-01-06
AU2021298800A1 (en) 2022-11-24
JP7539501B2 (ja) 2024-08-23
CL2022003329A1 (es) 2023-03-31
MX2022016357A (es) 2023-01-24
MA60100B1 (fr) 2025-11-28
TWI907452B (zh) 2025-12-11
BR112022021865A2 (pt) 2023-01-24
EP4171563A1 (en) 2023-05-03
AR122779A1 (es) 2022-10-05
DK4171563T3 (da) 2025-10-20
US11884652B2 (en) 2024-01-30
ES3049803T3 (en) 2025-12-18
LT4171563T (lt) 2025-10-10
CN121159510A (zh) 2025-12-19
WO2022002782A1 (en) 2022-01-06
CR20220667A (es) 2023-02-03
SA522441965B1 (ar) 2024-07-21
TW202216688A (zh) 2022-05-01
KR20230028547A (ko) 2023-02-28
IL299175A (en) 2023-02-01
US20250092019A1 (en) 2025-03-20
CN115803029B (zh) 2025-09-05
CN115803029A (zh) 2023-03-14
EP4171563B1 (en) 2025-08-06
HRP20251260T1 (hr) 2025-12-05
SI4171563T1 (sl) 2026-03-31
PE20231852A1 (es) 2023-11-21
FI4171563T3 (fi) 2025-10-22
CO2022016755A2 (es) 2022-11-29
JP2023531924A (ja) 2023-07-26
CA3181350A1 (en) 2022-01-06
JOP20220350A1 (ar) 2022-12-26
ECSP22088664A (es) 2022-12-30
RS67325B1 (sr) 2025-11-28
PT4171563T (pt) 2025-10-21
NZ793602A (en) 2025-02-28
CN121085901A (zh) 2025-12-09
DOP2022000262A (es) 2023-01-31

Similar Documents

Publication Publication Date Title
IL277455A (en) History of aminopyrimidines as CTPS1 inhibitors
EP3720495A4 (en) HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS
IL307448A (en) Phosphorus derivatives as novel inhibitors of SOS1
IL286363A (en) Benzodiazepine derivatives as rsv inhibitors
IL310403A (en) Converted pyridine derivatives as SARM1 inhibitors
IL273579A (en) Salts of pyrrolothrizine compounds used as tem inhibitors.
HUE070004T2 (hu) Tetrazol-származékok, mint TRPA1 inhibitorok
IL292093A (en) Thianopyrimidones as trpa1 inhibitors
IL306065A (en) Uracil history as TRPA1 inhibitors
IL309013A (en) Converted pyrimidinylpyrazoles as CDK2 inhibitors
IL319011A (en) Triazinone derivatives as NLRP3 inhibitors
PH12022550298A1 (en) Quinoline derivatives as protein kinase inhibitors
IL319009A (en) Triazinone derivatives as NLRP3 inhibitors
IL292095A (en) Thianopyrimidones as trpa1 inhibitors
HUE069955T2 (hu) Tetrazol származékok, mint TRPA1 inhibitorok
HUE073295T2 (hu) Tetrazol származékok mint TRPA1 gátlók
EP4029853A4 (en) SYNTHETIC METHOD APPLIED TO A HETEROCYCLIC INTERMEDIATE OF KRAS INHIBITOR DRUGS
IL314297A (en) N3-substituted URACIL compounds as TRPA1 inhibitors
IL288472A (en) Tetracyclic compounds as cdc7 inhibitors
EP3976038A4 (en) HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS
SG11202006394YA (en) Benzotriazole derivatives as corrosion inhibitors
IL310025A (en) Heterocyclic compounds as MAP4K1 inhibitors
ZA202100140B (en) Pyridopyrimidinone derivatives for use as axl inhibitors